Skip to main content

SB 1264 — Missouri

Removes the expiration date on certain provisions relating to gender transition

Introduced 2026 session Senate

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

SB 1264 - Currently, the prohibition on the prescription or administration of cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for persons under 18 years of age expires on August 28, 2027. This act removes that expiration date.

This act is identical to a provision in SB 861 (2026), SB 249 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024), substantially similar to HCS/HBs 2033, 1608, 1672, & 1854 (2026), SB 1200 (2026), and SB 75 (2025), and similar to provisions in HCS/HBs 1520, 1519, 2355, and 2357 (2024).
SARAH HASKINS

Official abstract, as published by the legislature.

  • SB 1264 is a bill in the Missouri Senate, 2026 session, introduced December 1, 2025.
  • Sponsored by Rick Brattin.
  • Current status: introduced.
  • Most recent action (January 27, 2026): Second Read and Referred S Families, Seniors and Health Committee.
  • Subjects: Children and Minors, Health Care, Health Care Professionals, Medical Procedures and Personnel.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Rick Brattin

History

  1. Introduced, completed
  2. Passed Senate, in progress
  3. Passed House, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. Senate Prefiled
  2. Senate S First Read
  3. Senate Second Read and Referred S Families, Seniors and Health Committee Latest

Source: Open States. Last checked November 1, 2026. How we keep this accurate ›